Sleep duration and daytime napping are not strongly linked to dementia risk, although there may be a small increase in risk associated with short sleep duration.
About 70% of the world's population will live in urban areas by 2050, emphasizing the importance of assessment tools to guide decisions towards more sustainable cities. The ‘Mandala ODS’ is an alternative tool promoted by the Brazilian government to quantify the sustainability of cities based on the UN SDGs. Although diagnoses are important steps for governance, the behavioral profile of decision makers also appears as a key aspect. This work aims to assess the potential association evidence among biophysical, socioeconomic and cultural variables with city sustainability as measured by the ‘Mandala ODS’. A sample of 130 Brazilian cities is considered as a sample, and the Pearson's chi-square indicator is calculated for association analysis. Results show that Brazilian cities located in the South/Southeast/Midwest regions, with HDI higher than 0.75, incidence of poverty lower than 40%, territorial area lower than 3,000 km2, and GDP/capita higher than 25,000 R$/person.yr,
Inre motståndskraft minskar behovet av bekämpningsmedel | forskning.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forskning.se Daily Mail and Mail on Sunday newspapers.
Using gene testing to assess the risk of breast cancer
Clinicians will soon be able to use gene panel testing to identify those most at risk from developing breast cancer, thanks to 2,000 DNA samples gathered in Ireland and which were used as part of an international study involving more than 113,000 women,
Peter Doyle reports
There are nine specific genes associated with breast cancer risk, according to the results of an international project with significant Irish involvement. The University of Cambridge-led BRIDGES (Breast Cancer Risk after Diagnostic Gene Sequencing) study aimed to identify women at high risk of breast cancer and to develop sensitive and informative gene panel testing for the prediction of breast cancer risk.